| 2018 | The prognostic value of volume-based parameters using<sup>18</sup>F-FDG PET/CT in gastric cancer according to HER2 status | 김효송, 라선영, 범승훈, 윤미진, 이충근, 정민규, 정현철, 조응혁 |
| 2017 | Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
| 강석민, 김지형, 김효송, 라선영, 박형순, 범승훈, 심지영, 이충근, 정민규, 정현철, 허수진, 홍그루 |
| 2017 | Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs | 김상우, 김성무, 김혜련, 양인석, 이충근, 조병철 |
| 2017 | Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab
| 김승섭, 김현기, 김효송, 라선영, 박소희, 이충근, 임준석, 정민규, 정현철, 허수진 |
| 2017 | PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
| 김주훈, 김태수, 라선영, 박형순, 이충근, 정현철, 허수진 |
| 2016 | Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy | 김형일, 김효송, 노성훈, 라선영, 안지영, 이충근, 정민규, 정용휴, 정인경, 정재호, 정현철, 허수진, 형우진 |
| 2016 | A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas
| 김규리, 이충근, 정민규, 조응혁, 최성훈, 한경석, 한규연, 허수진, 허혁 |
| 2015 | Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer
| 김정민, 라선영, 안중배, 이강영, 이명은, 이충근, 정현철 |
| 2015 | Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
| 김혜련, 김효송, 노미령, 라선영, 신상준, 안중배, 이충근, 정민규, 정현철, 최혜진, 허수진 |
| 2015 | Prediction of short- and long-term survival for advanced cancer patients after ICU admission | 김규리, 손주혁, 이수현, 이충근, 정경수, 최혜진, 허수진 |
